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doi:10.1016/j.jtcvs.2007.10.039Objective: The in-hospital safety of total arterial revascularization for coronary artery
bypass surgery seems to be comparable to conventional revascularization, but ran-
domized trials evaluating this are few and data on complications in the postoperative
months are sparse.
Methods: In a randomized single-center trial, 331 patients underwent total arterial
revascularization using single or bilateral internal thoracic and radial arteries versus
conventional revascularization using the left internal thoracic artery and saphenous
vein grafts. We report the results from 3 months’ follow-up.
Results: The mean age of patients was 596 8 years, and 39 were women (12%). The
median EuroSCORE was 2 (interquartile range 1–4). The arterial group comprised
161 patients, and the conventional group comprised 170 patients. The mean number
of bypasses in the arterial group was 2.9 6 0.9 versus 3.2 6 0.9 in the conventional
group (P5 .004). Three months’ follow-up for the arterial versus conventional groups
showed the following: deaths: 1 (0.6%) versus 0; stroke: 3 (1.9%) versus 3 (1.8%);
myocardial infarction: 6 (3.7%) versus 4 (2.4%); sternal wound reoperation: 4
(2.5%) versus 0 (P5 .054); arm and leg wound complications requiring hospitaliza-
tion: 3 (1.9%) versus 6 (3.5%) (P 5 .50), respectively.
Conclusion: These results confirm previous reports that total arterial revascularization
can be performed with low in-hospital morbidity and mortality. Further, in the 3 post-
operative months, total arterial revascularization did not lead to more complications or
admissions than conventional surgery. Arterial grafting was performed with signifi-
cantly fewer bypasses, but no differences in anginal status were seen after 3 months.
A tendency toward more sternal complications after arterial grafting was observed,
but clinical outcomes were comparable to conventional grafting.
C
oronary surgery is a well-documented operative procedure, but the main fac-
tors influencing long-term outcome have not undergone scientific scrutiny.
The standard conduits for coronary artery bypass grafting (CABG) have
long been the left internal thoracic artery (LITA) and saphenous vein grafts. Bypass
graft patency is an important factor to predict patient outcome after CABG, and the
unsatisfactory long-term results of vein grafts have led to an increased use of arterial
grafts.1 The internal thoracic artery (ITA) offers patients a survival benefit and supe-
rior graft patency compared with vein grafts.2 The use of bilateral internal thoracic ar-
tery (BITA) grafts seems to improve survival even further.3 The need for additional
grafts and concern about sternal complications after BITA harvest have increased
the use of the radial artery. The seemingly superior patency rates compared with
vein grafts have led to its revival.4 The combination of ITA and radial artery grafts
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CDAbbreviations and Acronyms
BITA 5 bilateral internal thoracic artery
CABG 5 coronary artery bypass grafting
ITA 5 internal thoracic artery
LAD 5 left anterior descending
LITA 5 left internal thoracic artery
PCI 5 percutaneous coronary intervention
RITA 5 right internal thoracic artery
TAR 5 total arterial revascularization
for total arterial revascularization (TAR) is scientifically ac-
cepted as a potentially superior treatment but is not com-
monly used.5,6 The evidence for its benefits is sparse. Few
large retrospective comparative series and randomized trials
show signs of superior graft patency and clinical out-
come.7-9 However, one randomized trial did not show differ-
ences in clinical outcome or patency after 5 years.10
The postoperative in-hospital safety and morbidity after
TAR seems to be comparable to that of conventional sur-
gery,7-9 but the impact on the months after patient discharge
is unknown. We compared CABG with the use of LITA or
BITA and the radial artery (ie, TAR) vs conventional revas-
cularization using LITA and saphenous vein grafts, in rela-
tively unselected patients with 2- or 3-vessel coronary
artery disease. In this article we focus on short-term peri-
and postoperative mortality and morbidity.
Materials and Methods
Trial Design
Patients were randomly allocated to 2 groups: TAR (primarily LITA
or BITA, and radial artery) or conventional revascularization (LITA
and vein grafts). The primary outcome measures are angiographic 1-
and 5-year distal anastomotic patency and cardiac event-free survival
at 1, 5, and 10 years postoperatively. Secondary outcome measures
are perioperative mortality and morbidity.
Ethics
The trial was conducted in accordance with the Helsinki Declaration,
is registered with ClinicalTrials.gov (number: NCT00159991), and
was approved by the Regional Research Ethics Committee for Co-
penhagen (number: [KF] 01-137/01). The funding agencies were
not involved in the data interpretation or other aspects of the trial.
Statistics
Sample size was calculated according to the primary outcome mea-
sure: 5-year distal anastomotic patency in the 2 groups. An absolute
patency difference of 15% in favor of TAR was regarded as clini-
cally relevant. To detect a difference of this magnitude at 5 years,
15% improved patency for arterial grafts (85% vs 70%), with a 90%
power and 5% level of significance, the group sizes were N 5
150.11 A total of 331 patients were included. Data were entered into
an Access database (Microsoft 2000; Microsoft Corp, Redmond,
Wash) and analyzed by intention to treat principles using the
Statistical Package for the Social Sciences 13.0 (SPSS Inc,1070 The Journal of Thoracic and Cardiovascular Surgery c MaChicago, Ill). Normally distributed continuous data were presented
as mean and standard deviation and analyzed using unpaired t
test. Median and quartiles and the Mann–Whitney test were
used for not normally distributed continuous data. Categoric
data are presented as number and percentages and analyzed using
the chi-square test with continuity correction or the Fisher exact
test as appropriate. All tests were 2-tailed.
Patient Inclusion
The day before surgery, patients were informed, written and oral
consent were obtained, and included patients received a trial number
and randomization code. Random allocation was stratified by sex
and diabetes state (insulin requiring). The coded randomization
envelopes were kept in a locked room at the surgical ward. A nurse
without relation to the trial handled and opened the envelopes.
Inclusion Criteria
Patients with 2- or 3-vessel coronary artery disease referred for elec-
tive or urgent CABG (.1 graft planned) were eligible provided they
were aged less than 70 years with a left ventricular ejection fraction
greater than 35%. Patients were required to have a normal Allen’s
test result and be able to give informed consent.
Exclusion Criteria
Patients were excluded from the trial for the following reasons: in case
of aneurysm of the left anterior descending (LAD) coronary artery,
concurrent malignant disease with expected survival less than 5 years,
unsuitable saphenous vein grafts evaluated preoperatively, emer-
gency operation, other concomitant heart surgery, or reoperation.
Anesthesia
Regardless of the type of revascularization, patients were anesthe-
tized in the same manner using midazolam, thiopental, fentanyl,
pancuronium, and isoflurane 0.4% to 1.0%. Infusion of propofol
was started after the end of perfusion. The infusion of nitroglycerin
was started before the aortic crossclamp was released.
Surgery
For surgery, median sternotomy and normothermic extracorporeal
circulation with primarily cold blood cardioplegia were used. The
radial artery or saphenous vein was harvested by the open technique
and the LITA or both thoracic arteries were prepared as pedicles.
Both radial artery and vein grafts were stored in a solution of verap-
amil 5 mg, nitroglycerin 2.5 mg, 500 IU of heparin, 0.2 mL of 8.4%
sodium bicarbonate, and 300 mL of Ringer’s solution.12 The same
surgeons performed both types of operations and contributed
equally to both groups. The operating surgeon decided how to per-
form the revascularization. A body mass index greater than 35 kg/
m2 combined with insulin-requiring diabetes was a contraindication
for the use of BITA. The radial artery was used as a single or sequen-
tial graft and anastomosed proximally to the aorta or used as a com-
posite graft. The right internal thoracic artery (RITA) was primarily
used as a pedicled graft. Saphenous vein grafts were proximally
anastomosed to the aorta and used as single and sequential grafts.
The LITA was primarily used as a graft to the LAD with or without
jumps to diagonal branches. Proximal aortic anastomoses were sewn
with Prolene 6-0 for arterial grafts and Prolene 5-0 for vein grafts.
All distal anastomoses and composite arterial graft anastomosesy 2008
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were graded smaller or larger than 1.5 mm by use of an intraluminal
probe.
Postoperative Care
The nitroglycerin infusion was continued to 6 AM the morning after
surgery in a dose of at least 0.5 mg/kg/min unless low blood pressure
prohibited this. From postoperative day 1, all patients in both groups
received amlodipine 5 mg increased to 10 mg for 3 months if toler-
ated. Aspirin and statin treatment were standard for all patients.
Three-month Follow-up
Clinical follow-up was conducted 1 to 2 months postoperatively at
referring hospitals. At 3 months, patients filled in a questionnaire an-
swering if there had been any admissions, complications, or change
in medication. Patients reporting complications were contacted by
telephone and seen by a project surgeon or cardiologist in the outpa-
tient clinic if indicated. All admissions within 90 days after the
operation were double-checked in the national Danish patient ad-
mission database (Green System, CSC Scandihealth), which stores
diagnoses and discharge letters from admissions at almost all hospi-
tals in Denmark. The hospitals not included are not in regions where
any of the trial patients lived, and no patients reported being admit-
ted to any of these hospitals.
Results
Patient Inclusion
Of 1969 isolated first-time CABG procedures (February 21,
2002, to February 22, 2005), 1136 patients were available
for screening. For flowchart, see Figure 1.The Journal of ThorBaseline Data
There were no differences in baseline data between the 2 groups
except that there were more patients in the conventional group
with previous stroke or transient cerebral ischemia (Table 1).
Overall, the indications for coronary angiography were as
follows: stable angina, 55.6%; non-ST-elevation myocardial
infarction, 26.6%; primary percutaneous coronary intervention
(PCI) for ST-elevation myocardial infarction, 8.5%; and unsta-
ble angina, 7.9%. Preoperatively, 91.5% of patients were taking
aspirin (1-week pause), 28.7% of patients were taking clopidog-
rel (1-week pause), 84.3% of patients were taking statins, 27.8%
of patients were taking angiotensin-converting enzyme inhibi-
tors, 11.8% of patients were taking angiotensin receptor
blockers, 76.7% of patients were taking beta-blockers, 21.5%
of patients were taking calcium channel blockers, and 58.3%
of patients were taking nitrates. At inclusion, 49.6% of patients
were smokers.
Operative Data
TAR group. It took a mean of 21 extra minutes to prepare
the arterial conduits (95% confidence interval 10–31 min-
utes), and blood cardioplegia was more often used (Table
2). LITAs were used as a sequential grafts in 19 cases
(11.8%), and RITAs were used as free grafts in 12 of 77 cases
(15.6%). The radial artery was used as a sequential graft in
54 of 128 patients (42.2%) and proximally anastomosed to
the aorta in 96 patients (75.0%). In 24 patients (14.9%),
a LITA to radial artery composite graft was constructed,AFigure 1. Flowchart. *Extreme obesity,
severe renal disease, severe handicap,
abuse or psychiatric disease, and se-
vere femoral atherosclerosis. zTakayasu
arteritis, concomitant ablation for atrial
fibrillation, urgent operation.acic and Cardiovascular Surgery c Volume 135, Number 5 1071
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graft was constructed. The 11 crossovers to conventional re-
vascularization were the result of inadvertent error by the sur-
geon in 6 cases (4 because of a positive Allen’s test
performed erroneously after randomization by the operating
surgeon and 1 because the radial artery was of poor quality).
Other protocol violations were as follows: 5 patients received
only a LITA to the LAD because this was the only graftable
vessel in 4 patients and the only bypass needed after review
of the preoperative angiography in 1 patient. This was also
the case in 2 patients receiving only a radial artery graft
and 1 patient erroneously receiving a vein graft, all to the
right coronary artery. One patient received a radial artery to
the LAD because the LITA was of poor quality and a border-
line obtuse marginal stenosis was scheduled for PCI. Three
patients received a vein graft in addition to arterial grafts
because of insufficient arterial graft length. Two patients
with insulin-requiring diabetes and body mass index greater
than 35 had BITA grafts.
Conventional group. Saphenous veins were used as
sequence grafts in 86 patients (50.6%). Of the 3 crossovers
TABLE 1. Preoperative clinical status
Type of revascularization
Total arterial
(n 5 161)
Conventional
(n 5 170)
Female sex 19 (11.8) 20 (11.8)
Age, y 59 6 8 59 6 8
Body mass index, kg/m2 27 6 4 28 6 4
CCS class $ 3 51 (31.7) 43 (25.3)
NYHA class $ 3 35 (21.7) 27 (15.9)
MI , 90 d 56 (34.8) 67 (39.4)
Atrial arrhythmia 8 (5.0) 4 (2.4)
Previous PCI 31 (19.3) 27 (15.9)
Hypertension 82 (50.9) 81 (47.6)
Hypercholesterolemia 140 (87.0) 147 (86.5)
Total cholesterol, mmol/L 5.2 6 1.2 5.3 6 1.2
Nonelective surgery 57 (35.4) 65 (38.2)
EuroSCORE* 2 1–3 3 1–4
COPD 9 (5.6) 14 (8.2)
Peripheral arterial disease 18 (11.2) 20 (11.8)
Cerebrovascular disease 3 (1.9) 13 (7.6)
Creatinine . 200 mmol/L 1 (0.6) 2 (1.2)
Diabetes: insulin 6 (3.7) 9 (5.3)
Diabetes: diet/tablets 33 (20.5) 34 (20.0)
LMS stenosis only 13 (8.1) 14 (8.2)
2-vessel disease 44 (27.3) 53 (31.2)
3-vessel disease 100 (62.1) 103 (60.6)
Ejection fraction 35%–49% 48 (29.8) 42 (24.7)
Ejection fraction $ 50% 113 (70.2) 128 (75.3)
CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association,
MI, myocardial infarction; PCI, percutaneous coronary intervention; COPD,
chronic obstructive pulmonary disease; LMS, left main stem coronary
artery. *Presented as number (%), mean6 standard deviation, and *median
and quartiles.1072 The Journal of Thoracic and Cardiovascular Surgery c Mto TAR, 2 were due to poor vein graft material and 1 was
due to inadvertent error by the surgeon. One patient received
a RITA graft in addition to a LITA and vein graft because
there was no more usable saphenous vein material. Six
patients received a jump LITA graft to a diagonal instead of
a vein graft. The inoperable patient had unexpected pericar-
dial carcinosis from lung cancer; he recovered fairly well
postoperatively and underwent incomplete revascularization
by PCI during another admission. Other protocol violations
were as follows: one patient received only a LITA to the
LAD because this was the only graftable vessel, 1 patient
was aged more than 70 years at inclusion, 6 patients under-
went operation by non-trial surgeons, 1 patient had an ejection
fraction less than 35%, and 1 patient underwent concomitant
carotid endarterectomy.
Postoperative stay. One patient in the TAR group died of
aortic rupture at reoperation of suspected graft failure a few
hours after the primary operation (Table 3). Two patients in
the TAR group had graft occlusion diagnosed at angiography
after signs of myocardial infarction (creatine kinase MB. 80
mg/L); 1 patient with an occluded LITA underwent PCI, and
1 patient with an occluded radial artery underwent reopera-
tion. Four patients in the conventional group underwent angi-
ography because of signs of myocardial infarction: One
patient had open grafts, 2 patients underwent reoperation
for vein graft occlusion, and 1 patient, who had an occluded
LITA and 1 occluded and 1 open vein graft, did not undergo
reoperation because of extensive diffuse atherosclerosis. PCI
was attempted without success. The patient recovered and
was discharged in relatively good condition. Two patients
in the conventional group had a perioperative stroke, 1 with
paraplegia and 1 with only aphasia who recovered almost
completely before discharge. The 8% of patients who were
not discharged directly to home were transferred to referring
hospitals for rehabilitation.
Three-month follow-up. There were no deaths or myo-
cardial infarctions reported and no significant differences in
complications requiring hospitalization (Table 4). Aspirin
was taken by 95.8% of patients, statins were taken by
91.7% of patients, beta-blockers were taken by 73.7% of pa-
tients, nitrates were taken by 3.5% of patients, and 22.4% of
patients were still smoking. There were no significant differ-
ences between groups, except 135 patients (88.8%) in the
TAR group and 121 patients (75.6%) in the conventional
group had taken calcium channel blockers (P 5 .004).
Per protocol analysis. Per protocol analysis of data from
the in-hospital stay and 3 months’ follow-up did not influence
the results (135 patients in the TAR group vs 147 patients in
the conventional group).
Discussion
Our results show comparable outcome 3 months after TAR
versus conventional revascularization. Performing randomized
trials of surgical procedures has never been straightforward.ay 2008
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Type of revascularization
Total arterial
(n 5 161)
Conventional
(n 5 170) P value
Operation time, min 192 6 51 172 6 45 .000
CPB time 73 6 22 70 6 23 .281
Crossclamp time 45 6 15 43 6 15 .398
Blood cardioplegia 130 (83.3) 114 (69.5) .006
Use of inotropic agents 23 (14.3) 19 (11.2) .494
Tranexamic acid 140 (87.0) 141 (82.9) .386
Aprotinin 8 (5.0) 8 (4.7) 1.000
Patients with:
Only BITA 15 (9.3) 2 (1.2) —
BITA and RA 61 (37.9) 1 (0.6) —
LITA and RA 63 (39.1) 1 (0.6) —
LITA and SVG 12 (7.5) 160 (94.1) —
Only LITA 5 (3.1) 2 (1.2) —
Only RA 3 (1.9) 0 —
Only SVG 1 (0.6) 3 (1.8) —
Only RITA and RA 1 (0.6) 0 —
Complete revascularization 128 (79.5) 141 (82.9) .509
Distal anastomoses 466 542 —
Distal anastomoses/patient 2.9 6 0.9 3.2 6 0.9 .004
Patients with:
0/1/2/3/4/$5 distal
anastomoses (%)*
0/8/44/70/35/4 (0/5/27/43/22/2) 1/1/37/71/47/13 (1/1/22/42/28/8) .033
Target vessel , 1.5 mm 138 (29.6) 162 (29.9) .979
CPB, Cardiopulmonary bypass; LITA, left internal thoracic artery; RITA, right internal thoracic artery; BITA, bilateral internal thoracic artery; RA, radial artery;
SVG, saphenous vein graft. Presented as number (%) and mean 6 standard deviation. Chi-square and t tests. *Percentages are rounded numbers.ANumerous factors complicate and influence the active interven-
tion itself, blinding is rarely possible, and patients cannot actu-
ally withdraw their consent once the operation has been
performed. These are obviously not the only difficulties we
have experienced, but despite the challenges, randomized trials
are necessary because relatively few surgical procedures are
evidence-based. This article reports the first results from the
largest randomized trial comparing TAR with conventional
CABG.
Baseline Data
The predominance of patients with cerebrovascular disease in
the conventional group is considered to be due to chance be-
cause of the relatively limited number of patients. More than
50% of screened patients were included in the trial, thereby
yielding a relatively high internal validity. Moreover, the
fact that 30% of vessel diameters were less than 1.5 mm doc-
uments that unselected patients were enrolled.
In-hospital
Overall, 81% of patients received bypass grafts to all in-
tended target vessels. Even so, the patients in the TAR group
received a mean of 0.3 fewer distal anastomoses (95% confi-
dence interval 0.1–0.5). Saphenous veins seem to offer moreThe Journal of Thoramaterial for grafting, and perhaps coronary lesions of minor
importance are left untreated more often in arterial grafting.
This is supported by the fact that the prevalence of angina
pectoris, according to the Canadian Cardiovascular Society
classification, was the same in the 2 groups after 3 months.
Muneretto and colleagues8 reported a mean distal anastomo-
sis number of 2.8 per patient in their trial of TAR.
The longer operation time and BITA harvest in itself may
have accounted for the tendency toward more transfusions,
primarily red blood cells, in the TAR group. BITA harvest
has been found to increase operation time and postoperative
bleeding.13 More patients in the TAR group received blood
cardioplegia, partly because nonproject surgeons using crys-
talloid cardioplegia performed operations in 6 patients in the
conventional group. This may have masked a difference in
the postoperative levels of creatine kinase MB and the need
for inotropes,14 but because only 16 (14%) more patients in
the arterial group than in the conventional group had blood
cardioplegia, the impact on our data seems limited.
As expected, the in-hospital perioperative morbidity and
mortality were similar in the 2 groups. Serious complications
were few in these low- to medium-risk patients. There was
a trend toward more arm wound complications in the TAR
group than leg wound complications in the conventionalcic and Cardiovascular Surgery c Volume 135, Number 5 1073
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had reduced hand force, and 1 patient had leg sensory distur-
bances. This could partly be because of an increased aware-
ness of complications from the arm compared with the leg.
Three-month Follow-up
It seems that patients undergoing TAR do not experience more
complications in the short-term postoperative period, but it is
surprising that a quarter of all patients had been readmitted.
This could be a result of the relatively short postoperative hos-
pital stays. Freedom from angina (Canadian Cardiovascular
Society class 1) at 3 months was more than 90%, even though
19% of patients were left with untreated coronary lesions.
Wound Complications
Four patients in the TAR group required readmission and
sternal rewiring, 1 because of deep infection. In 3 patients,
BITA was used. No patients had diabetes or a body mass in-
dex greater than 35. The difference between groups was only
borderline significant, but the use of BITA in comparison
with a single ITA seemed to increase the risk of sternal
TABLE 3. Postoperative stay
Type of revascularization
Total arterial
(n 5 161)
Conventional
(n 5 170)
P
value
Length of stay, d 6.9 6 2.1 7.1 6 3.1 .613
Ventilation time, h* 6 4–10 6 4–10 .444
Ventilator . 24 h 2 (1.2) 4 (2.4) .685
Peak CK-MB, mg/L* 19 14–25 20 15–26 .277
Inotropes 24 (14.9) 25 (14.7) 1.000
Atrial fibrillation 52 (32.3) 48 (28.2) .493
Transfusion 49 (30.4) 37 (21.8) .094
Superficial sternal
wound infection
0 2 (1.2) .499
Arm or leg wound
complication
5/130 (3.8) 1/167 (0.6) .090
Reoperation for
bleeding
3 (1.9) 4 (2.4) 1.000
Myocardial infarction
(CK-MB . 80)
6 (3.7) 4 (2.4) .533
Re-angiography 2 (1.2) 4 (2.4) .685
Reoperation for graft
failure
2 (1.2) 2 (1.2) 1.000
PCI 1 (0.6) 0 .486
IABP 2 (1.2) 0 .236
Stroke 0 2 (1.2) .499
Deaths 1 (0.6) 0 .486
Discharged directly
to home
147 (91.3) 158 (92.9) .727
CK-MB, Creatine kinase MB; PCI, percutaneous coronary intervention;
IABP, intraaortic balloon pump. *Presented as number (%), mean 6 stan-
dard deviation, and *median and quartiles. Mann–Whitney, t, Fisher exact,
and chi-square tests.1074 The Journal of Thoracic and Cardiovascular Surgery c Mdehiscence 10-fold: BITA 3 of 79 (3.8%) versus single ITA
1 of 250 (0.4%), relative risk 9.53, 95% confidence interval
1.01 to 90.34, P 5 .044. All cases of sternal dehiscence are
obviously not included in this because not all patients are di-
agnosed within 3 months. Follow-up after 1 year will help to
clarify this.
Fewer patients in the TAR group seemed to experience
any sort of motor dysfunction (primarily reduced strength)
in the arm or hand compared with patients in the conventional
group who had experienced motor dysfunction in the leg or
foot. Approximately one third of patients in both groups
reported sensory disturbances (numbness and paresthesia)
from the arm and hand, the leg and foot, or the scar. Patients’
perception of sensory disturbances after radial artery harvest
is probably more common than previously reported. Up to
68% of patients report any sort of sensory disturbances; how-
ever, they are self-limiting and of only minor importance to
patients.15 Approximately 20% of patients in both groups
TABLE 4. Three months' follow-up
Type of revascularization
Total arterial
(n 5 160)
Conventional
(n 5 170)
P
value
Patients readmitted 39 (24.4) 43 (25.3) .948
Readmission for:
Arm or leg wound complication 3 (1.9) 6 (3.5) .503
Atrial fibrillation 6 (3.8) 11 (6.5) .385
Observation for MI 9 (5.6) 6 (3.5) .516
Thoracentesis 6 (3.8) 4 (2.4) .532
Sternal rewiring 4 (2.5) 0 .054
Reoperation for PE 0 1 (0.6) 1.000
Pneumonia 2 (1.3) 6 (3.5) .285
PCI 0 1 (0.6) 1.000
Stroke 3 (1.9) 1 (0.6) .358
Other cardiac-related 9 (5.6) 6 (3.5) .516
Other noncardiac 8 (5.0) 10 (5.9) .912
Questionnaire follow-up: (n 5 152) (n 5 160)
CCS class 1 142 (93.4) 152 (95.0) .723
CCS class 2 10 (6.6) 7 (4.4)
CCS class 3 0 1 (0.6)
NYHA class 1 to 2 147 (96.7) 152(95.0) .637
NYHA class 3 5 (3.3) 8 (5.0)
Patients with atrial fibrillation 10 (6.3) 15 (8.8) .500
Arm or leg motor dysfunction 6/129 (4.7) 19/160 (11.9) .050
Arm or leg sensor dysfunction 35/129 (27.1) 54/160 (33.8) .279
Arm or leg wound complication 22/129 (17.1) 38/160 (23.8) .212
Total cholesterol, mmol/L 4.2 6 1.0 4.3 6 0.9 .778
MI,Myocardial infarction; PE, pericardial effusion; PCI, percutaneous coro-
nary intervention; CCS, Canadian Cardiovascular Society; NYHA, New York
Heart Association. Other cardiac-related 5 sudden loss of consciousness,
observation for suspected pulmonary embolism/pericardial effusion. Other
noncardiac 5 urogenital, gastrointestinal or malignancy. *Presented as
number (%). Chi-square, Fisher exact, and t tests.ay 2008
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cause of complicated arm or leg wound healing or superficial
wound infection. However, only 1 patient in the TAR group
had been admitted for arm wound infection and treated with
intravenous antibiotics; another patient had an arm wound
hematoma surgically evacuated. A third patient in the TAR
group was admitted for an infected leg wound. The 6 patients
in the conventional group who were admitted with an in-
fected leg wound were treated with intravenous antibiotics,
and 2 patients also needed surgical revision.
Conclusions
These first results from the Copenhagen Arterial Revascular-
ization Randomized Patency and Outcome (CARRPO) trial
comparing total arterial with conventional revascularization
confirm previous reports that TAR can be performed with
low in-hospital morbidity and mortality. During the 3 postop-
erative months, arterial revascularization did not lead to more
complications and admissions than conventional CABG. Ar-
terial grafting may lead to slightly fewer bypasses, but clini-
cal outcomes were comparable to conventional grafting. The
results from the 1-year follow-up will help to clarify whether
arterial grafts lead to superior graft patency and clinical
outcome.
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